Visit
What is Lunit?
Lunit Inc. is a company specializing in leveraging artificial intelligence (AI) to create cutting-edge technology for cancer screening and treatment. By harnessing the power of AI, Lunit's solutions facilitate the early identification of cancer and forecast the efficacy of treatment, leading to significant life-saving outcomes.
Information
- Financing
- $135.87M
- Revenue
- $2.51B
- Language
- English
- Price
- Paid
Freework.ai Spotlight
Display Your Achievement: Get Our Custom-Made Badge to Highlight Your Success on Your Website and Attract More Visitors to Your Solution.
Website traffic
- Monthly visits--
- Avg visit duration--
- Bounce rate--
- Unique users--
- Total pages views--
Access Top 5 countries
Oops, no data.
Traffic source
Lunit FQA
- What is Lunit's AI technology used for?
- Who has expressed interest in utilizing Lunit's AI?
- What research results will Lunit showcase at ESMO 2023?
- What is the diagnostic performance of Lunit's AI-powered mammography analysis solution?
- Where are Lunit's offices located?
Lunit Use Cases
Lunit AI can be used in breast cancer screening, replacing one human reader in Europe.
Lunit AI can be used in radiology for CXR, CXR Triage, MMG, and DBT.
Lunit AI can be used in oncology for SCOPE IO and SCOPE PD-L1.
Lunit AI has been validated in 200+ studies and abstracts.
Lunit AI has won 1st place in the Visual Domain Adaptation Challenge.
Lunit AI has been used in day-to-day practices by customers.
Lunit AI is being introduced to Inje University Paik Hospital nationwide.
Lunit AI is used by over 2,000 sites worldwide.
Lunit AI is expected to usher in new precision oncology products.
Lunit AI has been showcased in 9 AI-based research results at ESMO 2023.
Lunit AI has been validated as a game-changer in breast cancer screening.
Lunit AI achieves comparable diagnostic performance with human readers in mammography analysis.
Follow us on Twitter